Literature DB >> 12167692

Imatinib mesylate and gray hair.

Gabriel Etienne, Pascale Cony-Makhoul, François-Xavier Mahon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12167692     DOI： 10.1056/NEJM200208083470614

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Medication-Induced Repigmentation of Gray Hair: A Systematic Review.

Authors:  Katerina Yale; Margit Juhasz; Natasha Atanaskova Mesinkovska
Journal:  Skin Appendage Disord       Date:  2019-12-17

2.  Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potential.

Authors:  Catherine Delbaldo; Sandrine Faivre; Chantal Dreyer; Eric Raymond
Journal:  Ther Adv Med Oncol       Date:  2012-01       Impact factor: 8.168

3.  Hypopigmentation in an African patient treated with imatinib mesylate: a case report.

Authors:  Syed Hasan; Kimberly Dinh; Fred Lombardo; Fitzroy Dawkins; John Kark
Journal:  J Natl Med Assoc       Date:  2003-08       Impact factor: 1.798

4.  Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor.

Authors:  Hawk Kim; Heung-Moon Chang; Min-Hee Ryu; Tae-Won Kim; Hee-Jung Sohn; So-Eun Kim; Hye-Jin Kang; Sarah Park; Jung-Shin Lee; Yoon-Koo Kang
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

5.  Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.

Authors:  Tariq I Mughal; Andrew Schrieber
Journal:  Biologics       Date:  2010-12-02

6.  Evaluation of the safety of imatinib mesylate in 200 iraqi patients with chronic myeloid leukemia in the chronic phase: single-center study.

Authors:  Bassam Francis Matti; Alaa Fadhil Alwan; Alaa Fadhil Alwan
Journal:  Turk J Haematol       Date:  2013-12-05       Impact factor: 1.831

Review 7.  European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Authors:  J L Steegmann; M Baccarani; M Breccia; L F Casado; V García-Gutiérrez; A Hochhaus; D-W Kim; T D Kim; H J Khoury; P Le Coutre; J Mayer; D Milojkovic; K Porkka; D Rea; G Rosti; S Saussele; R Hehlmann; R E Clark
Journal:  Leukemia       Date:  2016-04-28       Impact factor: 11.528

8.  Repigmentation and new growth of hairs after anti-interleukin-17 therapy with secukinumab for psoriasis.

Authors:  Franco Rongioletti; Cristina Mugheddu; Severino Murgia
Journal:  JAAD Case Rep       Date:  2018-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.